Relating drug–protein interaction network with drug side effects
Open Access
- 3 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 28 (18) , i522-i528
Abstract
Motivation: Identifying the emergence and underlying mechanisms of drug side effects is a challenging task in the drug development process. This underscores the importance of system–wide approaches for linking different scales of drug actions; namely drug-protein interactions (molecular scale) and side effects (phenotypic scale) toward side effect prediction for uncharacterized drugs. Results: We performed a large-scale analysis to extract correlated sets of targeted proteins and side effects, based on the co-occurrence of drugs in protein-binding profiles and side effect profiles, using sparse canonical correlation analysis. The analysis of 658 drugs with the two profiles for 1368 proteins and 1339 side effects led to the extraction of 80 correlated sets. Enrichment analyses using KEGG and Gene Ontology showed that most of the correlated sets were significantly enriched with proteins that are involved in the same biological pathways, even if their molecular functions are different. This allowed for a biologically relevant interpretation regarding the relationship between drug–targeted proteins and side effects. The extracted side effects can be regarded as possible phenotypic outcomes by drugs targeting the proteins that appear in the same correlated set. The proposed method is expected to be useful for predicting potential side effects of new drug candidate compounds based on their protein-binding profiles. Supplementary information: Datasets and all results are available at http://web.kuicr.kyoto-u.ac.jp/supp/smizutan/target-effect/. Availability: Software is available at the above supplementary website. Contact:yamanishi@bioreg.kyushu-u.ac.jp, or goto@kuicr.kyoto-u.ac.jpKeywords
This publication has 29 references indexed in Scilit:
- Predicting drug side-effect profiles: a chemical fragment-based approachBMC Bioinformatics, 2011
- PubChem as a public resource for drug discoveryDrug Discovery Today, 2010
- Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated frameworkBioinformatics, 2010
- KEGG for representation and analysis of molecular networks involving diseases and drugsNucleic Acids Research, 2009
- Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP InhibitorsPLOS Computational Biology, 2009
- A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysisBiostatistics, 2009
- Predicting drug side-effects by chemical systems biologyGenome Biology, 2009
- Drug Target Identification Using Side-Effect SimilarityScience, 2008
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- SuperTarget and Matador: resources for exploring drug-target relationshipsNucleic Acids Research, 2007